Palavras-chave
Como Citar
Resumo
Graves' orbitopathy is a complex and debilitating ophthalmological condition often associated with the autoimmune thyroid disease known as Graves' disease. Characterized by inflammation and swelling of the tissues around the eyes, Graves' orbitopathy can lead to a range of serious symptoms, such as proptosis (bulging eyes), diplopia (double vision), eye pain and impaired visual function. Eye plastic surgery emerges as an important therapeutic approach to restore not only ocular health, but also the quality of life of affected patients, aiming to correct the physical and functional deformities associated with the condition. However, critical evaluation of the scientific literature on the topic is essential to understand the effectiveness, safety and results of the different surgical procedures used in this context. Objective: The objective of this systematic review is to analyze studies published in the last 10 years on ocular plastic surgery for Graves' orbitopathy, with the aim of evaluating the effectiveness, safety and results of the different surgical procedures used to treat this condition. Methodology: Using the PRISMA checklist, articles were searched in the PubMed, Scielo and Web of Science databases, published between 2012 and 2020. The descriptors used were "Graves' Orbitopathy", "Ocular Plastic Surgery", "Thyroid Eye Disease" , "Graves' ophthalmopathy" and "eyelid reconstruction". and "eyelid reconstruction". Inclusion criteria: studies in English, evaluating surgical procedures for Graves' orbitopathy, with clinical and quality of life results. Exclusion criteria: duplicate studies, samples unrelated to Graves' orbitopathy and without relevant clinical results. Results: The main topics covered by the studies include surgical techniques, visual results, postoperative complications and impact on patients' quality of life. Conclusion: The systematic review highlights the importance of ocular plastic surgery in the management of Graves' orbitopathy, providing insights into the most effective and safe surgical approaches to restore ocular health and quality of life to affected patients.
Referências
Rossetto JD, Gracitelli CPB, Osaki TH, Osaki MH. Diseases, conditions, and drugs associated with cicatricial ectropion. Arq Bras Oftalmol . 2019;82(4):345-353. Published 2019 May 20. doi:10.5935/0004-2749.20190068
Asano ME, Osaki MH. Quality of life assessment in patients with blepharoptosis. Arq Bras Oftalmol . 2006;69(4):545-549. doi:10.1590/s0004-27492006000400016
França VP, Figueiredo AR, Vasconcelos AC, Oréfice RL. Experimental comparative study of bioactive composite with polymeric matrix for applications to oculoplastic surgery for tissue replacement. Arq Bras Oftalmol . 2005;68(4):425-431. doi:10.1590/s0004-27492005000400003
González-García A, Sales-Sanz M. Treatment of Graves' ophthalmopathy. Treatment of Graves' ophthalmopathy. Med Clin (Barc) . 2021;156(4):180-186. doi:10.1016/j.medcli.2020.07.031
Caballero Mora FJ, Martos Moreno GA, Gutiérrez Partida B, Argente J. Oftalmopatía y enfermedad de Graves [Graves' ophthalmopathy]. An Pediatr (Barc) . 2012;77(5):355-356. doi:10.1016/j.anpedi.2012.04.007
Pampín-Sánchez R, Martínez-Mugica-Barbosa C, Fonseca-Aizpuru EM, Barbazán-Vázquez FJ, Fernández-González B, Buznego-Súárez L. Outcome of tocilizumab treatment in corticosteroid-resistant thyroid eye disease. Med Clin (Barc) . 2023;160(3):113-117. doi:10.1016/j.medcli.2022.05.007
Sánchez-Sevila JL. Thyroid ophthalmopathy of Miguel Hernández Gilabert. Thyroid ophthalmopathy by Miguel Hernández Gilabert. Arch Soc Esp Oftalmol (Engl Ed) . 2018;93(6):e37-e39. doi:10.1016/j.oftal.2017.10.011
Vilar-González S, Lamas-Oliveira C, Fagúndez-Vargas MA, et al. Thyroid orbitopathy, an overview with special attention to the role of radiotherapy. Endocrinol Nutr . 2015;62(4):188-199. doi:10.1016/j.endonu.2014.12.004
de-Pablo-Gómez-de-Liaño L, Fernández-Vigo JI, Troyano-Rivas J, Niño-Rueda C, Romo-López Á, Gómez-de-Liaño R. Response to tocilizumab treatment in Graves' ophthalmopathy by measuring rectus muscle thickness and chemosis using optical coherence tomography. Evaluation of extraocular muscle thickness and chemosis after tocilizumab in Graves' ophthalmopathy using optical coherence tomography. Arch Soc Esp Oftalmol (Engl Ed) . 2018;93(8):386-391. doi:10.1016/j.oftal.2018.04.011
Magalhães CH, Pereira MD, Manso PG, Veiga DF, Novo NF, Ferreira LM. Self-esteem in the inactive form of Graves' ophthalmopathy. Arq Bras Oftalmol . 2008;71(2):215-220. doi:10.1590/s0004-27492008000200015
Metello JL, González M, Eusébio R, Rocha V. Thyroid associated ophthalmopathy. Acta Med Port . 2004;17(4):329-334.
Fernández Hermida RV, Pinar S, Muruzábal N. Manifestaciones clinicas de la oftalmopatía thyroidea [Clinical manifestations of thyroid ophthalmopathy]. An Sist Sanit Navar . 2008;31 Suppl 3:45-56.
Este trabalho está licenciado sob uma licença Creative Commons Attribution 4.0 International License.
Copyright (c) 2024 Jessica Gabriele Rosa Silva , Kamilla Silva Bispo, Fernanda Alkmim Rezende Teixeira, Renato Anatolio Lima Horta Maciel, Luana Magalhães Trindade